Latent Lines

UUUU — UUUU

4.94% of the book · -10.15% since entry · entered 2024 or

UUUU Policy v0.1 (formalized 2026-05-13 — supersedes earlier "monthly add" framing)

Role classification: Strategic uranium + heavy rare earth processing bottleneck. Not a conventional uranium miner. Vertically integrating mine (Donald JV) → oxide separation (White Mesa) → metallization (KMP/AMP via pending ASM acquisition).

Research verdict: Grade A- "Accumulate" per project/research/UUUU-Energy-Fuels-Diligence-Research-Plan.md, downgraded by Senior Dev to "Hold / Selective Accumulate" given current portfolio weight.

Position weight currently above the 4.5% no-add threshold. The no-add gate is binding until weight retraces.

Action mandate: HOLD. NO ADDS until ALL of the following are met simultaneously:

  1. Price below $18 (gives high-margin entry to uranium cash flow + REE/ASM optionality essentially free)
  2. Weight below 4.5%
  3. No thesis-break events (see hold-unless conditions below)

The combined constraint means even a 12% UUUU drop to $18 is insufficient if portfolio doesn't grow in parallel. Realistic trigger requires UUUU drop to ~$16.50 OR meaningful portfolio appreciation that pulls UUUU weight back under 4.5%.

Hold unless (thesis-break conditions): - ASM acquisition fails to close in Q3 2026 (kills mine-to-metal integration thesis) - Malagasy government revokes Vara Mada development permits (kills generational REE volume) - Major White Mesa operational halt under Clean Air Act / RCRA / Offsite Rule litigation - Vara Mada / Donald JV both fail simultaneously (eliminates global monazite feedstock pipeline)

Verified catalysts (any of these = potential add trigger even above $18 if weight allows): - ASM transaction close (target July 2026) - Donald Project FID (target mid-to-late 2026) - Pilot Dy/Tb commercial-scale recovery validation (Q3-Q4 2026) - Vara Mada Madagascar resolution (12-24 months) - DFARS 2027 China-decoupling enforcement (January 2027) - Medical isotope pilot first batch (late 2026)

Review trigger: Q2 2026 earnings (August 2026) — confirm ASM integration, Pinyon Plain unit costs, Phase 2 timeline.

Capped call dilution ceiling: Above $30.70, up to 45.6M shares can convert from the $700M convertible notes. This is a structural price ceiling that caps parabolic upside.

REA cross-link (validated 2026-05-13 via separate diligence): REA's monazite strategy explicitly depends on UUUU's White Mesa toll processing. REA = feedstock; UUUU = chokepoint. The REA position (1 sh probe) is effectively a free option on UUUU's customer pipeline. UUUU may be the better expression of the heavy-REE thesis than REA itself.

Listing Note

Dual-listed: Primary on NYSE American as UUUU. Also listed on Toronto Stock Exchange as EFR.TO. US SEC filings (10-K, 10-Q) are the authoritative source. SEDAR+ has Canadian cross-listing filings.

One-line thesis

The only US uranium producer also producing commercial rare earth elements from domestic monazite, giving UUUU a two-catalyst story: uranium supply deficit repricing AND domestic REE independence -- the only name in the portfolio that covers both critical mineral themes simultaneously.

Position

  • T2+T4 tactical-tranche position; primary core entered Sept 2025 (LTCG-eligible from Sept 2026 onward). One STCG-locked May 2026 lot held through ~May 2027.
  • Add discipline: no adds above the $25 analyst-consensus ceiling. Current price below ceiling.

Thesis (detailed)

Energy Fuels is the largest US uranium producer by licensed capacity, operating the White Mesa Mill in Utah -- the only conventional uranium mill operating in the US. This physical infrastructure advantage is not easily replicated; permitting and construction for a new conventional mill would take 10+ years. White Mesa processes both uranium ore and monazite sand, making UUUU the only company in the Western Hemisphere commercially producing separated rare earth carbonates (including terbium, the first commercial terbium production in the US) from a single integrated facility.

The uranium supply deficit thesis is well-documented: global uranium demand from long-term utility contracts is projected to peak around 2030, with supply from existing mines structurally inadequate. The Prohibiting Russian Uranium Imports Act (signed May 2024) removes Russian TENEX supply from the US market, increasing domestic supply urgency. UUUU's licensed production capacity at White Mesa and its ISR operations (Pinon Plain, Nichols Ranch) position it to benefit from contract repricing as utilities scramble for non-Russian supply.

The REE layer adds asymmetric optionality. China's export restrictions on heavy rare earths (terbium, dysprosium) -- critical for EV motors, wind turbines, and defense systems -- are driving US government urgency to establish a domestic supply chain. UUUU's first commercial terbium production is a direct response to this gap. The Pentagon and DOE are active customers; DoD funding for White Mesa REE processing is an ongoing program. This is not exploratory -- it is operating production. Combined analyst consensus is $27.25 (mean of 5 analysts), HC Wainwright target $29, strong buy.

Recent catalysts (60-day rolling)

  • 2026-05-06 to 05-07: +9.5% move on 05-06 (close $23.52 from open $21.47) on 13.9M vol (1.3x avg) -- uranium sector strength, possible terbium/REE policy news; -1.3% giveback 05-07 on 22.7M vol (2.1x avg, elevated -- distribution)
  • 2026-04-30: +8.3% (close $21.64 from open $19.98) -- broad uranium sector recovery; Apr bottom reversal
  • 2026-04-13 to 04-15: Two-day +5-6% recovery from April lows after sector-wide sell-off
  • 2026-03-02: +11.8% single day (close $23.37, open $20.90) on 15.1M vol (1.4x avg) -- uranium spot price catalyst or macro shift; Jan 28, 2026 52-week high $27.90 established on 30.2M vol (2.9x avg, +10.9% intraday)
  • 2026-01-28: 52-week peak $27.90 -- highest price in the research window; strong sector momentum coinciding with DNN and URG also peaking

Note: March-April 2026 saw sustained selling from $23+ range back to ~$16.46 (March 30 low -- 52-week low during this period was $4.20 in May 2025 before the uranium thesis trade). Price recovered from $16.46 to current ~$21.

Risks / What would break the thesis

  • Uranium spot price sustained collapse below $55/lb -- would impair White Mesa economics and reduce urgency for new US supply contracts; current spot estimated ~$65-70/lb range (couldn't verify exact May 12 UxC spot -- check Cameco UxC or TradeTech)
  • REE thesis disruption: US-China diplomatic normalization removes urgency for domestic terbium/dysprosium production; or China resumes unrestricted exports; destroys the REE premium
  • White Mesa operational disruption -- mill shutdown (permitting issue, environmental challenge, tailings facility capacity) would eliminate the sole US conventional milling capability
  • Dilution risk: 249.9M shares outstanding with market cap ~$5.2B (yfinance). Any secondary offering at or below $21 would be dilutive; monitor 13D/A and S-3 filings
  • Analyst ceiling discipline: HC Wainwright target $29, consensus mean $27.25. Mike's rule is to not add above $25 ceiling. Position concentration should not increase above ceiling even if thesis remains intact.
  • Capital raise at wrong time: totalCash $910.7M vs totalDebt $677.5M -- balance sheet is reasonable but any equity raise near current prices dilutes the STCG lot

Triggers

  • Add discipline: no adds above the $25 analyst-consensus ceiling.
  • DO NOT add above $25 (analyst consensus ceiling discipline per PORTFOLIO_CONTEXT)
  • DO NOT TRIM the May 12, 2026 lot before May 2027 (STCG)
  • Watch: Q2 2026 earnings (date not confirmed at writeup -- check IR calendar; typically August for June quarter-end)
  • Watch: DoD REE contract renewals or expanded scope at White Mesa
  • Watch: Uranium spot price crossing $80/lb -- would likely trigger analyst target revisions above $29
  • Watch: Any DoE/DoD announcement on domestic REE supply chain (terbium/dysprosium procurement)

External authoritative sources

Open questions / hypotheses

  1. What is the current uranium spot price (UxC index or TradeTech) as of May 12, 2026? The thesis economics are highly sensitive to whether spot is above or below $65/lb. Couldn't verify exact current price -- run market-context.py against URA or check Cameco commentary.
  2. What volume of terbium (in kg or tonnes) has White Mesa produced commercially, and what is the realized price per kg? This is the key metric to validate that terbium production is not just symbolic but economically meaningful.
  3. Has DoD extended or expanded its White Mesa REE processing contract for 2026-2027? Any new procurement announcement would be a material positive catalyst.
  4. What is the Q2 2026 earnings date? Do not enter within 3 days (beta 1.609 -- below the >3 threshold, but standard discipline applies; confirm before adding).
  5. The 52-week low of $4.20 (yfinance data from May 2025 period) suggests the uranium thesis trade Mike executed in July 2025 occurred near the bottom -- exceptional timing. What was the catalyst for the $4.20 floor? Understanding the floor logic helps size the current risk.

Decision log

  • 2025-09 (approx): Initial position established under the uranium supply-deficit thesis. Position scaled through 2025-2026 monthly adds.
  • 2026-05-12: Wiki page created. Position governed under UUUU Policy v0.1 (4.5% max-weight no-add threshold; $25 analyst-ceiling discipline).